Search - tctmd.com

Displaying 521 - 540 of 1293

Sort: Relevancy | Date

Presentation TCT 2017

Clinical Trials Using RAPID: Some POC Thoughts

Presenter: Schuyler Jones, Hiroyoshi Yokoi, Theodore Heise

October 30, 2017

Presentation TCT 2017

RAPID Program: Industry View

Presenter: Schuyler Jones, Hiroyoshi Yokoi, Robert Thatcher

October 30, 2017

Presentation TCT 2017

RAPID Program: Academic View

Presenter: Schuyler Jones, Hiroyoshi Yokoi

October 30, 2017

Presentation TCT 2017

RAPID Program: PMDA View

Presenter: Schuyler Jones, Hiroyoshi Yokoi, Yoshimasa Yokoyama

October 30, 2017

Presentation TCT 2017

Registry Assessment of Peripheral Interventional Devices (RAPID) Program

Presenter: Schuyler Jones, Hiroyoshi Yokoi, Eleni Whatley

October 30, 2017

News Daily News

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

L.A. McKeown

October 18, 2017

News Daily News

Same-Day Discharge After PAD Procedures Safe in Elderly Patients

L.A. McKeown

October 09, 2017

Presentation CDM 2017

Severe Pad with No Percutaneous Options: The Paradigm Shift with PQ Bypass

Presenter: Richard R. Heuser

October 06, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2017

Shelley Wood

September 30, 2017

Presentation VIVA 2017

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Presenter: Ehrin J. Armstrong

September 19, 2017

News Industry News

Eurocor announces the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen

September 19, 2017

News Conference News VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

L.A. McKeown

September 18, 2017

News Daily News

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

Yael L. Maxwell

September 15, 2017

News Features

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

Todd Neale

September 15, 2017

Presentation VIVA 2017

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

Presenter: Michael Dake

September 14, 2017

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Industry News

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

September 12, 2017

News Conference News ESC 2017

Acute MI Mortality Has Dropped to Very Low Levels in France

Todd Neale

September 08, 2017

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

August 30, 2017

News Conference News ESC 2017

VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost?

Shelley Wood

August 28, 2017

Advertisement

Clinical Trials Using RAPID: Some POC Thoughts

RAPID Program: Industry View

RAPID Program: Academic View

RAPID Program: PMDA View

Registry Assessment of Peripheral Interventional Devices (RAPID) Program

Lower Limb Revascularizations Increasing in PAD Patients on Dialysis

Same-Day Discharge After PAD Procedures Safe in Elderly Patients

Severe Pad with No Percutaneous Options: The Paradigm Shift with PQ Bypass

TCTMD’s Top 10 Most Popular Stories for September 2017

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Eurocor announces the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

Acute MI Mortality Has Dropped to Very Low Levels in France

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content